Leucocyte-depleted blood cardioplegia

Area of Science:

• Cardiovascular Surgery
• Immunology
• Inflammation Research

Background:

• Cardiopulmonary bypass (CPB) triggers an inflammatory response, potentially causing myocardial reperfusion injury.
• Leucocyte depletion is a strategy to mitigate this inflammatory response during cardiac surgery.

Purpose of the Study:

• To investigate the effect of leucocyte-depleted (LD) cardioplegia on the inflammatory response and myocardial protection in patients with unstable angina undergoing CPB.
• To determine if LD cardioplegia attenuates endothelial and neutrophil-mediated inflammation post-CPB.

Main Methods:

• Randomized study comparing a leucocyte-depleted (LD) group with a control group.
• Patients received either LD isothermic blood cardioplegia or standard isothermic blood cardioplegia.
• Blood samples analyzed for leucocyte counts, adhesion molecules, cytokines, elastase, and malondialdehyde at multiple time points.

Main Results:

• Cardioplegia blood leucocyte counts were significantly lower in the LD group.
• No significant differences in systemic leucocyte or neutrophil counts post-CPB between groups.
• Adhesion molecules, cytokines, elastase, and malondialdehyde increased similarly in both groups after CPB.

Conclusions:

• LD cardioplegia and reperfusion did not attenuate the CPB-induced inflammatory response.
• The strategy did not prevent endothelial and neutrophil-mediated inflammation, suggesting it may not protect against myocardial reperfusion injury.